Literature DB >> 1733347

Rosai-Dorfman disease of soft tissue.

E A Montgomery1, J M Meis, G Frizzera.   

Abstract

Whereas Rosai-Dorfman disease (RDD) or sinus histiocytosis with massive lymphadenopathy is well described in lymph nodes and other organs, it is frequently not recognized in soft tissue. We studied the clinical and histologic features of 23 previously unreported soft tissue lesions from 17 patients (13 females, 4 males) who were 24 to 66 years of age (mean, 46 years). These lesions involved the extremities (12, 52%), trunk (6, 26%), head and neck (3, 13%), and the retroperitoneum (2, 9%). Associated lymph node involvement was present in four cases; most patients were asymptomatic. RDD of soft tissue had more subtle histologic features than its lymph node counterpart. Emperipolesis was less conspicuous and proliferating histiocytes were frequently spindled, associated with collagen deposition, and arranged in a vague storiform pattern with scattered lymphoplasmacytic aggregates. These features led to a variety of diagnoses, including benign inflammatory and fibrohistiocytic lesions (13 cases) as well as lymphoma and malignant fibrous histiocytoma (three cases). RDD was correctly diagnosed in only one case. Diagnosis was confirmed in 16 of 18 lesions by detection of S-100 protein and histiocytic markers KP1 (12 of 13) and lysozyme (eight of 11) in the characteristic histiocytes. Recognition that RDD of soft tissue occurs in an older patient population than does nodal RDD and that it mimics fibrous and inflammatory lesions of soft tissue is important.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733347     DOI: 10.1097/00000478-199202000-00004

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  15 in total

1.  [Isolated Rosai-Dorfman disease].

Authors:  A M Gassel; D M Lamskemper; J Sold-Darseff; J G Müller; H K Müller-Hermelink
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

2.  Rosai-Dorfman disease: isolated epibulbar masses in two adult patients.

Authors:  T A Albini; M Evans; R See; N A Rao; E Marback; M M de Souza
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

3.  Inflammatory pseudotumour and Rosai-Dorfman disease of soft tissue: a histological continuum?

Authors:  D Govender; R Chetty
Journal:  J Clin Pathol       Date:  1997-01       Impact factor: 3.411

4.  Intracranial inflammatory tumors: a survey of their various etiologies by presentation of 5 cases.

Authors:  E Postler; A Bornemann; M Skalej; S Kröber; E Kaiserling; J Wickboldt; R Meyermann
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

5.  Rosai-Dorfman disease presenting as multiple soft tissue masses.

Authors:  Phillip M Young; Mark J Kransdorf; H Thomas Temple; Fatemeh Mousavi; Philip G Robinson
Journal:  Skeletal Radiol       Date:  2005-05-14       Impact factor: 2.199

6.  Soft Tissue Rosai-Dorfman Disease: Case report.

Authors:  Rubyath C Rajib; Rajasekharan Pillai; Ibrahim A Sulaiman; Ibrahim Al-Haddabi
Journal:  Sultan Qaboos Univ Med J       Date:  2018-01-10

7.  [Extranodal Rosai Dorfman disease (sinus histiocytosis with massive lymphadenopathy). Report of 5 cases].

Authors:  W Hindermann; D Katenkamp
Journal:  Pathologe       Date:  2004-05       Impact factor: 1.011

8.  Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders.

Authors:  M Paulli; A C Feller; E Boveri; S Kindl; E Berti; R Rosso; H Merz; F Facchetti; C Gambini; F Bonetti
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

9.  Sinus histiocytosis with massive lymphadenopathy Rosai-Dorfman: three unusual manifestations.

Authors:  Gudrun Ratzinger; Bettina Zelger; Walter Höbling; Gregor Mikuz; Bernhard W Zelger
Journal:  Virchows Arch       Date:  2003-12       Impact factor: 4.064

10.  Extranodal Rosai-Dorfman disease presenting as an isolated epibulbar mass.

Authors:  Rajat Maheshwari; Satish Shekde
Journal:  Indian J Ophthalmol       Date:  2008 Nov-Dec       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.